FDA Forum 2024: FDA for Dermatologists

The FDA Forum 2024 featured Markham Luke, the Director of the Division of Therapeutic Performance at the FDA, who introduced the event and outlined its agenda. Luke emphasized the importance of FDA's role in regulating dermatological products, highlighting the various centers involved in this area, particularly the Center for Drug Evaluation and Research (CDER), which primarily regulates dermatology drugs. He welcomed Jill Lindstrom as the new director of the Division of Dermatology and Dental Drug Products and mentioned the significance of generic drugs, which constitute 90% of prescriptions in the U.S. The forum also prepared participants for a talk by Linda Katz, the Director of the Office of Cosmetics and Colors, focusing on cosmetic regulations in the U.S. Luke discussed the interconnections among various FDA centers handling devices, biologics, and veterinary products, underscoring their relevance to dermatology. The FDA's history and milestones in drug approval processes, particularly for dermatological products over the past year, were highlighted, including the introduction of new drugs and generics. Finally, Luke mentioned a publication detailing various chapters on FDA's contributions to dermatology, emphasizing the organization's ongoing efforts to ensure safety and efficacy in dermatological care.